Production of influenza pseudotyped lentiviral particles and their use in influenza research and diagnosis: an update.
about
Cleavage of hemagglutinin-bearing lentiviral pseudotypes and their use in the study of influenza virus persistencePseudotype-based neutralization assays for influenza: a systematic analysis.Pseudovirus-based neuraminidase inhibition assays reveal potential H5N1 drug-resistant mutations.Substitution at aspartic acid 1128 in the SARS coronavirus spike glycoprotein mediates escape from a S2 domain-targeting neutralizing monoclonal antibodyComparison of serological assays to titrate Hantaan and Seoul hantavirus-specific antibodiesA single residue substitution in the receptor-binding domain of H5N1 hemagglutinin is critical for packaging into pseudotyped lentiviral particles.An Innovative Pseudotypes-Based Enzyme-Linked Lectin Assay for the Measurement of Functional Anti-Neuraminidase Antibodies.Overview of Serological Techniques for Influenza Vaccine Evaluation: Past, Present and Future.The human Transmembrane Protease Serine 2 is necessary for the production of Group 2 influenza A virus pseudotypes.Insect cells as a production platform of complex virus-like particles.Application of virus-like particles (VLP) to NMR characterization of viral membrane protein interactions.Autophagy mediates avian influenza H5N1 pseudotyped particle-induced lung inflammation through NF-κB and p38 MAPK signaling pathways.The use of equine influenza pseudotypes for serological screeningDevelopment of in vitro and in vivo neutralization assays based on the pseudotyped H7N9 virus.Technical considerations for the generation of novel pseudotyped virusesThe application of pseudotypes to influenza pandemic preparedness
P2860
Q30366190-40EB1751-6781-40E2-AB76-7423D4A40893Q30374662-063AB855-ED21-46B6-8B4D-A12FDA02C711Q30429450-13F2621E-7714-448A-BCD8-A5B79144714FQ33897964-DE904B49-EEE5-470D-962D-9AB07E012434Q33916955-D4BFBDEC-B7C8-4C32-A8EF-A12C09F78475Q34469486-C95F2ACF-16F6-4499-A2F9-74876D47F814Q35744237-817321D9-0B68-45C6-AB2C-560ABC10B43BQ35826733-8E2FAED2-908F-4430-BC27-0BFC3D9DC783Q36734159-A81E1D3C-64D4-444D-8499-AFC83CF71C19Q38081976-8A6E9B1C-7A24-416A-82F5-D128E0934862Q38790676-20190A89-2820-46D6-8136-95553EBCD6D6Q39062263-37B0781D-3D38-43D2-8011-2F714DC3E856Q39670834-FDF11AEB-1E39-4273-979C-024F62A23B0EQ55308512-340B9B94-43E8-4AB2-A3CD-255D3248FA8CQ57275154-92947417-7C77-44CA-8747-7CDA0F4C4758Q58382401-690BEA23-4879-4E07-9ED9-C1CB123A0E93
P2860
Production of influenza pseudotyped lentiviral particles and their use in influenza research and diagnosis: an update.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Production of influenza pseudo ...... arch and diagnosis: an update.
@en
Production of influenza pseudo ...... arch and diagnosis: an update.
@nl
type
label
Production of influenza pseudo ...... arch and diagnosis: an update.
@en
Production of influenza pseudo ...... arch and diagnosis: an update.
@nl
prefLabel
Production of influenza pseudo ...... arch and diagnosis: an update.
@en
Production of influenza pseudo ...... arch and diagnosis: an update.
@nl
P2860
P356
P1476
Production of influenza pseudo ...... arch and diagnosis: an update.
@en
P2093
Jean-Michel Garcia
Jimmy C C Lai
P2860
P304
P356
10.1586/ERI.11.25
P577
2011-04-01T00:00:00Z